[ad_1]
3 hours ago
European stocks end higher
European stocks rose slightly on Monday, with the Stoxx 600 index up 0.17% after gaining 1.4% last week.
Britain’s FTSE 100 index rose 0.22%, while France’s CAC40 index was flat and Germany’s DAX index fell 0.15%.
See chart…
STOXX 600 index.
5 hours ago
AstraZeneca executive says lung cancer results show strategy is working
Greg Rossi, senior vice president of European and Canadian oncology at British-Swedish drugmaker AstraZeneca, told CNBC that the three lung cancer developments the company has announced in recent days bode well for the company’s current strategy. he said.
“This shows that our strategy, centered around our portfolio, the idea of addressing treatments early when there is a chance of cure, is really delivering results that truly benefit patients. “We have the opportunity to bring that to the table,” Rossi said.
“The portfolio approach of providing medicines to all lung cancer patients, regardless of stage, is now beginning to bear fruit,” he added.
A clinical trial of AstraZeneca’s lead cancer drug Tagrisso showed “overwhelming efficacy” in treating a type of lung cancer, the company announced Monday. Meanwhile, the U.S. Food and Drug Administration has approved the use of Tagrisso for certain types of lung cancer and accepted another drug, DatoDXd, for review as a lung cancer treatment.
AstraZeneca shares rose 3% in afternoon trading.
— Jenny Reid
10 hours ago
Temenos stock rebounds 6.5% after backlash over Hindenburg report
Shares in Swiss software company Temenos rose more than 6.5% in early trading on Monday, rebounding from a sharp decline last weekend.
The company’s stock fell 6% on Friday, adding to a 28% drop the previous day after the company’s board issued a statement saying it “fundamentally refutes” a report by short seller Hindenburg Research. I put it on.
The report alleges “characteristics of earnings manipulation and serious accounting fraud” at Temenos, based on a four-month investigation that included interviews with 25 former employees of the company.
Tenemos shares were up 6.7% by 9:40 a.m. London time.
— Karen Gilchrist
12 hours ago
Stock gains: AstraZeneca up 3.4%, Vector down 3%
AstraZeneca shares rose 3.4% in early trading Monday after the U.S. Food and Drug Administration approved the company’s blockbuster cancer drug Tagrisso to be used in combination with chemotherapy to treat a type of lung cancer.
Meanwhile, shares in German IT company Vector fell 3% after receiving an “underweight” rating from Barclays citing the company’s limited profit outlook this year.
— Karen Gilchrist
20 hours ago
CNBC Pro: A ‘good year’ for stocks: Morgan Stanley’s Slimmon recommends 3 stocks to buy right now
The stock market has been very strong so far, with the S&P 500 index closing above 5,000 for the first time last week.
“I think that’s very encouraging, because it means that earnings expectations for this year are not going to go down, they could potentially go up, and that’s important to the market,” said Managing Director and CEO said Andrew Slimmon, Senior Portfolio Manager. Morgan Stanley Investment Management told CNBC.
This year will be a “good year for stocks,” Slimmon said, naming three of his favorite stocks.
CNBC Pro subscribers can read more here.
— Amara Balakrishna
20 hours ago
CNBC Pro: These are the only two ETFs that have made money every year for the past 10 years
According to research by CNBC Pro, only two exchange-traded funds around the world that invest in defensive stocks have posted positive returns every year over the past 10 years.
These two funds stood out among 8,300 equity ETFs from around the world reviewed by CNBC Pro. Both funds have more than doubled investors’ cash over the past decade.
CNBC Pro subscribers can read more here.
— Ganesh Rao
15 hours ago
European Market: Click here for opening call
European markets are set to open in negative territory on Monday.
The UK’s FTSE 100 index is expected to open 19 points lower at 7,692, Germany’s DAX is down 44 points to 17,069, France’s CAC is down 23 points to 7,745 and Italy’s FTSE MIB is expected to open 19 points lower at 7,692, according to IG data. It is expected to open at 31,716, down 91 points.
January new car registration data for Italy, Germany, France, the Netherlands and the UK is due to be released on Monday.
— Holly Ellyatt
[ad_2]
Source link
